InsiderClue
Insiders · Profile

Shaaltiel Yoseph

Executive VP, R&D at Protalix BioTherapeutics. Filing since 5 Dec 2007. CIK 0001385118

Company
Date
Role
Action
Shares
Amount
Of holding
PLX Protalix BioTherapeutics, Inc.
2 May 2012
Executive VP, R&D
Sold, plan not stated
300,000
$2.14M
39.3%
PLX Protalix BioTherapeutics, Inc.
6 Aug 2010
Executive VP, R&D
Sold, plan not stated
4,619
$32.33K
0.6%
PLX Protalix BioTherapeutics, Inc.
5 Aug 2010
Executive VP, R&D
Sold, plan not stated
48,408
$338.86K
5.9%
PLX Protalix BioTherapeutics, Inc.
21 Jun 2010
Executive VP, R&D
Sold, plan not stated
52,973
$370.81K
6.1%
PLX Protalix BioTherapeutics, Inc.
29 Apr 2010
Executive VP, R&D
Sold, plan not stated
12,691
$88.84K
1.4%
PLX Protalix BioTherapeutics, Inc.
14 Apr 2010
Executive VP, R&D
Sold, plan not stated
1,309
$9.16K
0.1%
PLX Protalix BioTherapeutics, Inc.
25 Mar 2010
Executive VP, R&D
Sold, plan not stated
50,000
$350.00K
5.4%
PLX Protalix BioTherapeutics, Inc.
24 Mar 2010
Executive VP, R&D
Sold, plan not stated
202,700
$1.44M
17.8%
PLX Protalix BioTherapeutics, Inc.
23 Mar 2010
Executive VP, R&D
Sold, plan not stated
127,300
$893.65K
10.1%
PLX Protalix BioTherapeutics, Inc.
19 Oct 2009
Executive VP, R&D
Sold, plan not stated
43,120
$406.62K
3.3%
PLX Protalix BioTherapeutics, Inc.
16 Oct 2009
Executive VP, R&D
Sold, plan not stated
25,680
$241.14K
1.9%
PLX Protalix BioTherapeutics, Inc.
15 Oct 2009
Executive VP, R&D
Sold, plan not stated
31,200
$292.97K
2.3%
PLX Protalix BioTherapeutics, Inc.
6 Jul 2009
Executive VP, R&D
Sold, plan not stated
100,000
$509.40K
6.8%
PLX Protalix BioTherapeutics, Inc.
14 May 2009
Executive VP, R&D
Sold, plan not stated
10,000
$38.50K
0.7%
PLX Protalix BioTherapeutics, Inc.
13 May 2009
Executive VP, R&D
Sold, plan not stated
20,000
$70.20K
1.3%
PLX Protalix BioTherapeutics, Inc.
13 Mar 2009
Executive VP, R&D
Sold, plan not stated
8,300
$18.09K
0.6%
PLX Protalix BioTherapeutics, Inc.
19 Dec 2007
Executive VP, R&D
Bought
4,800
$16.32K
0.2%
PLX Protalix BioTherapeutics, Inc.
18 Dec 2007
Executive VP, R&D
Bought
5,100
$17.34K
0.2%
PLX Protalix BioTherapeutics, Inc.
17 Dec 2007
Executive VP, R&D
Bought
5,000
$16.75K
0.2%
PLX Protalix BioTherapeutics, Inc.
5 Dec 2007
Executive VP, R&D
Bought
15,100
$47.39K
0.5%
20 decisions on file.